Incidence of Bcr-Abl kinase domain mutations in imatinib refractory chronic myeloid leukemia patients from South India

Sailaja Kagita, Srihari Uppalapati, Sangeeta Jiwatani, Vijay Gandhi Linga, Sadasivudu Gundeti, Narayana Nagesh, Raghunadharao Digumarti
  • Tumor Biology, April 2014, Springer Science + Business Media
  • DOI: 10.1007/s13277-014-1926-9

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1007/s13277-014-1926-9

The following have contributed to this page: Narayana Nagesh and Dr Sadashivudu Gundeti